FDA Inspection 1283028 — Zhejiang Huahai Pharmaceutical Technology Co., Ltd.
The FDA completed an inspection of Zhejiang Huahai Pharmaceutical Technology Co., Ltd. on August 22, 2025 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 22, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)